Sáenz Abad D, Ruiz-Ruiz F J, Monón Ballarín S, Mozota Duarte J, Marquina Barcos A
Servicios de Urgencias, Hospital Clínico Universitario Lozano Blesa, Zaragoza.
An Med Interna. 2008 Jan;25(1):27-30. doi: 10.4321/s0212-71992008000100007.
Methotrexate (MTX) is a folic acid antagonist that inhibits cellular reproduction. MTX has been shown to be an effective anti-inflammatory agent. Acute interstitial pneumonitis is the main pulmonary side effect during MTX treatment. We report a case of MTX pneumonitis in a 56-year old woman with autoimmune thrombocytopenia who presented with subacute nonproductive cough, dyspnea at rest, fever, and malaise. Chest roentgenogram demonstrated bilateral diffuse interstitial and alveolar infiltration. Infectious diseases were ruled out and methotrexate-induced pneumonitis was suspected. MTX was discontinued and methylprednisolone was prescribed. Patient improved progressively. After eight weeks, radiologic abnormalities and symptoms had disappeared.
甲氨蝶呤(MTX)是一种抑制细胞增殖的叶酸拮抗剂。MTX已被证明是一种有效的抗炎药物。急性间质性肺炎是MTX治疗期间主要的肺部副作用。我们报告一例56岁患有自身免疫性血小板减少症的女性发生MTX肺炎,该患者表现为亚急性干咳、静息时呼吸困难、发热和不适。胸部X线片显示双侧弥漫性间质和肺泡浸润。排除了感染性疾病,怀疑是甲氨蝶呤诱发的肺炎。停用MTX并开具了甲泼尼龙。患者逐渐好转。八周后,影像学异常和症状消失。